Skip to main content

What lies ahead following Oklahoma opioid judgment

By The New York Times / Associated Press  
   August 27, 2019

Oklahoma's $572 million judgment against Johnson & Johnson will likely be followed by more trials and legal settlements seeking to hold a drug company accountable for a U.S. opioid crisis that has ripped apart lives and communities.

Full story


Get the latest on healthcare leadership in your inbox.